openPR Logo
Press release

Scientists Move Towards A HIV Cure

05-30-2011 09:13 AM CET | Health & Medicine

Press release from: Informed Horizons, LLC

Dr. Alain Lafeuillade and Dr. Mario Stevenson, are pleased to announce the 5th International Workshop on HIV Persistence During Therapy, to be held December 6-9, 2011 in St Maarten, West Indies. The Workshop will be of invaluable importance for scientists working towards a HIV cure.

Toulon, France, May 29, 2011 -- Dr. Alain Lafeuillade, Toulon, France and Dr. Mario Stevenson, University of Miami, USA are pleased to announce the 5th International Workshop on HIV Persistence During Therapy, to be held December 6-9, 2011. This Workshop will include the participation of the finest scientific minds in the world. As these researchers progressively move towards developing a HIV Cure, the continuing exchange of information, data, and experiments in a highly dedicated meeting is of utmost importance.

The International Workshop provides an invaluable tool for scientists who are working towards a cure for this pandemic to share important information regarding their research. More than 7,000 people each day are infected with HIV/AIDS. Since 1981, more than 60 million people have been infected, with half of those already died from HIV/AIDS. The expense of antiretroviral treatment for patients is astronomical and the attempts to provide universal access to treatment and care has proven financially unsustainable. Therefore, the only solution to this disease is to find a cure. The issues that have been identified as scientists have made major advances in finding a cure, has been the disinterest of investors and lack of commitment on the part of most politicians.

Since the 2008, cure of the Berlin Patient, the feasibility of a cure for HIV has become more viable and researchers throughout the world are taking different approaches to addressing the infection.

Sessions at this year's International Workshop will include, but are not limited to:








Speakers and presenters from around the world will be joining the Workshop to share their research findings and information. This will be a great opportunity to expand your knowledge-base as well as your network of scientists and researchers working towards the same goal. The invaluable information you will find at the Workshop will provide the catalyst for substantial dialogue and information sharing.

To get more information and details about the advantages and benefits of attending the 5th International Workshop on HIV Persistence During Therapy, visit today.

Members or the press or individuals wishing to get more information how this press release and how the Workshop will help scientists move towards a HIV cure will find contact information below.

Informed Horizons, LLC

Contact Information:
Alain Lafeuillade, MD, PhD Chief Department of Infectious Diseases
General Hospital
83100 TOULON
Tel: 33-4-94616340

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scientists Move Towards A HIV Cure here

News-ID: 177136 • Views:

More Releases from Informed Horizons, LLC

Hope for a Cure Against HIV
Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are the main hurdle to achieving HIV eradication. This paper provides information on the mechanisms of HIV persistence and a discussion on the critical questions facing researchers in the field. Tucker, GA, May 28, 2011 -- Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are
New Discoveries Expected at the Scientific Workshop on HIV Reservoirs
Tucker, GA - April 21, 2011 -- Controlling HIV replication without the need of life-long antiretroviral therapy (ART) is the next frontier scientists are addressing. Researchers involved in the fields of HIV reservoirs and eradication have just released the preliminary program of a workshop they will organize later this year, where scientific breakthroughs are expected. Fifteen years ago, when ART was discovered, a renewed optimism for a cure gained several scientists
Researchers United to Find a HIV cure
HIV persistence is an area of importance to many scientists working on a possible cure for HIV, and every two years a reference workshop is held to bring the world's top scientists together for a meeting of the minds. Researchers from several different fields will therefore attend its next edition, December 6-9, 2011. The preliminary program of this workshop has just been released, and the four-day seminar is packed with

All 4 Releases

More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral